Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023.

Eur Thyroid J · 2025 · PMC12598928 · PMID 41104970

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

With advances in targeted therapy and immunotherapy, ATC patients in our cohort showed a trend toward improved survival of 9.5 months compared to historical data of 3 months ( 6 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.